Serum protein kinase Cα as a diagnostic biomarker of cancers

Cancer Biomarkers

Volumn 13, Issue 2, 2013, Pages 99-103

  Kang, Jeong Hun ^a,d   Mori, Takeshi ^a   Kitazaki, Hirotaro ^a   Niidome, Takuro ^a   Takayama, Koichi ^b   Nakanishi, Yoichi ^b   Katayama, Yoshiki ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c International Research Center for Molecular Systems   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Diagnosis; peptide substrate; phosphorylation; protein kinase; serum

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; PROTEIN KINASE C ALPHA; ROTTLERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER THERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE, TUMOR; HUMANS; MALE; MICE; NEOPLASMS; PEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84880540875     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130340     Document Type: Article

References (21)

1. D. Sidransky, Emerging molecular markers of cancer. Nat Rev Cancer 2 (2002) 210-219. (Pubitemid 37328790)
2. K.J. Martin, M.W. Foumier, G.P. Reddy, A.B. Pardee, A need for basic research on fluid-based early detection biomarkers. Cancer Res 70 (2010) 5203-5206.
3. A. Odjélé, D. Charest, P. Jr Morin, miRNAs as important drivers of glioblastomas: A no-brainer? Cancer Biomark 11 (2012) 245-252.
4. J. Hofmann, Protein kinase C isozymes as potential targets for anticancer therapy. Curr Cancer Drug Targets 4 (2004) 125-146. (Pubitemid 38332552)
5. H.J. Mackay, C.J. Twelves, Targeting the protein kinase C family: Are we there yet? Nat Rev Cancer 7 (2007) 554-562. (Pubitemid 46985395)
6. C.A. Chen, R.H. Yeh, X. Yan, D.S. Lawrence, Biosensors of protein kinase action: from in vitro assays to living cells. Biochim Biophys Acta 1697 (2004) 39-51. (Pubitemid 38326760)
7. H. Ross, C.G. Armstrong, P. Cohen, A non-radioactive method for the assay of many serine/threonine-specific protein kinases. Biochem J 366 (2002) 977-981.
8. J.H. Kang, D. Asai, S. Yamada, R. Toita, J. Oishi, T. Mori, T. Niidome, Y. Katayama, A short peptide is a protein kinase C (PKC)α-specific substrate. Proteomics 8 (2008) 2006-2011. (Pubitemid 351775780)
9. J.H. Kang, D. Asai, R. Toita, H. Kitazaki, Y. Katayama, Plasma protein kinase C (PKC)α as a biomarker for the diagnosis of cancers. Carcinogenesis 30 (2009) 1927-1931.
10. J.H. Kang, M. Kuramoto, T. Tsuchiya, R. Toita, D. Asai, Y.T. Sato, M. Takeshi, T. Niidome, Y. Katayama, Correlation between phosphorylation ratios by matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis and enzyme kinetics. Eur J Mass Spectrom 14 (2008) 261-265.
11. A. Tsuchiya, D. Asai, J.H. Kang, T. Mori, T. Niidome, Y. Katayama, Correlation between phosphorylation ratios by MALDI-TOF MS analysis and radioactivities by radioactive assay. Anal Biochem 421 (2012) 773-775.
12. CJ. Bennetto, J.R. King, M.L. Turner, J.S.A. Stringer, E.P. Acosta, Effects of concentration and temperature on the stability of nevirapine in whole blood and serum. Clin Chem 50 (2004) 209-211. (Pubitemid 38125722)
13. B.L. Boyanton, K.E. Blick, Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 48 (2002) 2242-2247. (Pubitemid 35397569)
14. J.M. Herbert, M. Clowers, HJ. Lea, M. Pascal, A.W. Clowes, Protein kinase C α expression is required for heparin inhibition of rat smooth muscle cell proliferation in Vitro and in Vivo. J Biol Chem 271 (1996) 25928-25935. (Pubitemid 26347426)
15. G. Pintus, B. Tadolini, M. Maioli, A.M. Posadino, L. Gaspa, C. Ventura, Heparin down-regulates the phorbol ester-induced protein kinase C gene expression in human endothelial cells: enzyme-mediated autoregulation of protein kinase C-α and -δ genes. FEBS Lett 449 (1999) 135-140. (Pubitemid 29192893)
16. K. Aoyagi, Y. Kuzure, S. Shahrzad, A. Hirayama, S. Nagase, A. Ueda, Inhibition by heparin of protein kinase C activation and hydroxyl radical generation in puromycin aminonucleoside treated isolated rat hepatocytes. Mol Cell Biochem 244 (2003) 3-9. (Pubitemid 36411046)
17. S.P Davies, H. Reddy, M. Caivano, P. Cohen, Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95-105.
18. M. Gschwendt, S. Dieterich, J. Rennecke, W. Kittstein, HJ. Mueller, FJ. Johannes, Inhibition of protein kinase C μ, by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett 392 (1996) 77-80. (Pubitemid 26276722)
19. B.L.J. Webb, SJ. Hirst, M.A. Giembycz, Protein kinase C isoenzymes: A review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis. Br J Pharmacol 130 (2000) 1433-1452. (Pubitemid 30611917)
20. A. Kishimoto, K. Mikawa, K. Hashimoto, I. Yasuda, S. Tanaka, M. Tominaga, Kuroda T, Nishizuka Y Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (Calpain). J Biol Chem 264 (1989) 4088-4092. (Pubitemid 19072301)
21. F.L. Huang, Y Yoshida, J.R. Cunha-Melo, M.A. Beaven, K.P. Huang, Differential down-regulation of protein kinase C isozymes. J Biol Chem 264 (1989) 4238-4243. (Pubitemid 19072322)